Author

Matthew C. Griffor

Pfizer (United States)ORCID 0000-0003-4850-5545Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:E. coli· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:protein structure· 1

Frequent Co-Authors

Alexandre Esadze· 1 shared Alexey V. GribenkoiD· 1 shared Annaliesa S. AndersoniD· 1 shared Arthur Illenberger· 1 shared Christopher Ponce· 1 shared David R. Keeney· 1 shared Huixian WuiD· 1 shared J. Jasti· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Alexandre Esadze

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologyPLoS PathogensPeer-reviewedFeb 19, 2025

Structure-Based Design of a Highly Immunogenic, Conformationally Stabilized FimH Antigen for a Urinary Tract Infection Vaccine

Natalie C. Silmon de Monerri, Ye Che, Joshua A. Lees…·Robert G. K. Donald

The paper designs a conformationally stabilized FimH antigen for a UTI vaccine, showing improved immunogenicity and structural similarity to native FimH.

20 citationstop 3%

E. coliprotein structure

𝕏 PostBluesky